Adtalem Global Education announces new $150M stock buyback

Adtalem Global Education (ATGE) announced that its board of directors has authorized a new share repurchase program, which allows Adtalem to repurchase up to $150 million of its common stock through May 2028. In connection with today’s announcement, Adtalem disclosed that it completed its January 2024 board-authorized $300 million share repurchase program on May 5, 2025, representing a significant return to shareholders. The completed repurchase program had been authorized through January 2027. “The accelerated completion of our share purchase authorization reflects our unwavering confidence in Adtalem’s strong fundamentals and the enduring value of our Growth with Purpose strategy,” said Steve Beard, chairman and chief executive officer, Adtalem Global Education. “Recent market dislocations have created compelling opportunities to purchase shares at attractive valuations, enhancing shareholder value. Moving forward, we will maintain a disciplined yet dynamic allocation approach, prioritizing investments to expand program capacity across our portfolio to drive accelerated growth through 2027 and beyond. By leveraging robust cash flow, we aim to broaden access to high-demand healthcare education, bring new capacity to market and return excess to shareholders.”